Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | FAAH | O00519 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.39 |
| ▸ | NAMPT | P43490 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 3/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | GAA | P10253 | 2/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.37 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.37 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.36 |
| ▸ | CASP6 | P55212 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3668188 | 1.00 | ALDH1A1 (0.41) | ALDH1A1FAAHCYP2C9NAMPTMAPT | |
| SCHEMBL888609 | 0.79 | FAAH (0.43) | ALDH1A1FAAHCYP2C9NAMPTMAPT | |
| SCHEMBL2801383 | 0.79 | FAAH (0.43) | ALDH1A1FAAHCYP2C9NAMPTMAPT | |
| SCHEMBL7657363 | 0.75 | FAAH (0.44) | ALDH1A1FAAHCYP2C9NAMPTMAPT | |
| SCHEMBL9703437 | 0.75 | FAAH (0.43) | ALDH1A1FAAHCYP2C9NAMPTMAPT | |
| SCHEMBL7664015 | 0.74 | ALDH1A1 (0.43) | ALDH1A1FAAHCYP2C9NAMPTMAPT | |
| SCHEMBL8404155 | 0.74 | ALDH1A1 (0.43) | ALDH1A1FAAHCYP2C9NAMPTMAPT | |
| SCHEMBL5001740 | 0.73 | ALDH1A1 (0.42) | ALDH1A1CYP2C9MAPTCHRNB2CHRNA4 | |
| SCHEMBL7104208 | 0.72 | FAAH (0.43) | ALDH1A1FAAHCYP2C9NAMPTMAPT | |
| SCHEMBL7106276 | 0.72 | NAMPT (0.41) | ALDH1A1FAAHCYP2C9NAMPTMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1776116-B1 | VETERINARY COMPOSITION COMPRISING AN ARYLPYRAZOLE AND A NITROENAMINE WITH ENHANCED ANTIPARASITIC ACTIVITY | INTERVET INT BV (NL) | 2010-09-29 | — | — | EP | claimed |
| US-20070142447-A1 | Veterinary composition comprising an arylpyrazole and a nitroenamine with enhanced antiparasitic activity | INTERVET INTERNATIONAL B.V. (NL) | 2007-06-21 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070142447-A1 | Veterinary composition comprising an arylpyrazole and a nitroenamine with enhanced antiparasitic activity | AADAC, NISCH, NAT1 | ALDH1A1 1354/4885FAAH 607/4885CYP2C9 133/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.